Global Infectious Disease Control hampered by the CBD Nagoya Protocol So far, none of the models used by international networks of biobanks to arrange the legal responsibility under the CBD-Nagoya protocol works efficiently.
Tuberculosis in the spotlights A large international congress on tuberculosis will start in The Hague on October 24.
RIVM visits German Environment Agency (UBA) On 17 and 18 October 2018, RIVM visited the German Environment Agency Umwelt Bundesamt (UBA).
The introduction of the colorectal cancer screening programme in the Netherlands In 2014, a colorectal cancer screening programme was launched in the Netherlands. In a factsheet we describe the lessons learned during the introduction of this nationwide programme.
Sustainability Day at RIVM: Microplastics Today, 10 October 2018, is national Sustainability Day in the Netherlands.
Issue 2 of our newsletter is out now! Issue 2 of our quarterly newsletter is out now. It features the best read news stories and background information on public health and the environment from RIVM in the third quarter of 2018.
Alternatives available for environmentally detrimental antifouling paints There are various systems without biocides available that can serve as alternatives for antifouling paints on pleasure boats to prevent the growth of algae and shellfish on the hull.
Proposal to calculate combined effects of chemicals in the environment at EU level Current legislation for chemicals insufficiently covers the combined effects of substances on humans and the environment.
Eating less salt can prevent tens of thousands of heart attacks and strokes Lowering the amount of salt in processed foods or choosing low-salt alternatives can lead to substantial health benefits when it comes to cardiovascular disease.
Flu season in the winter of 2014 / 2015 more severe and longer than preceding years The flu epidemic in the winter of 2014 / 2015 lasted 21 weeks and as such was the longest epidemic ever recorded in the Netherlands. Nearly two million people suffered from flu-like symptoms.